Screener
Jade Biosciences JBIO Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Jade Biosciences’s reported figures.
Based on trailing twelve months.
The source filing: Jade Biosciences’s 10-Q, filed August 13, 2025. Open the filing →
- Filed
- Aug 13, 2025
- Fiscal quarter
- Q2 FY2025
- Calendar quarter
- Q2 2025
- Accession
- 0001193125-25-179853
FAQ
- What is Jade Biosciences's return on equity?
- Jade Biosciences (JBIO) reported return on equity of -132.5% in Q2 2025.
- How has Jade Biosciences's return on equity changed year-over-year?
- Jade Biosciences's return on equity decreased by 47.5% year-over-year, from -89.8% to -132.5%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Jade Biosciences's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude